Previously, studies in our laboratory have revealed: an association between TrkB levels tumor progression and patient prognosis in gastric cancer [23]; the association of TrkB with chemotherapy resistance in esophageal cancer [24]; and TrkB's involvement in the EMT of colorectal cancer [25]. This evidence concerns the gene NTRK2 and neoplasm.